GILEAD SCIENCES, INC. — Director's Dealing 2019

Feb 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-01-31

Reporting Person: BARTON JACQUELINE K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-31	Common Stock	M	480	—	Acquired	13740	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-31	Restricted Stock Unit	$	M	480	Disposed		Common Stock (480)	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2: 100% of the restricted stock units vested on January 31, 2019.